Hypolipidemic and Antioxidant Effects of Guishe Extract from Agave lechuguilla, a Mexican Plant with Biotechnological Potential, on Streptozotocin-Induced Diabetic Male Rats.
Edgar R Esquivel-GutiérrezSalvador Manzo-AvalosDonovan J Peña-MontesAlfredo Saavedra-MolinaZoé P MorreeuwAna G ReyesPublished in: Plants (Basel, Switzerland) (2021)
In the present study, we used a by-product from Agave lechuguilla (guishe) to test its antidiabetic effect, hypolipidemic activity, and capacity to mitigate the oxidative stress in kidney mitochondria from streptozotocin-induced diabetic rats. Orally, a crude aqueous extract from lyophilized guishe was administered over 5 weeks at different doses. Blood glucose and body weight were monitored. Also, blood chemistry, bilirubin, and alanine aminotransferase were assayed. Furthermore, the activity of catalase, thiobarbituric acid reactive species, mitochondrial superoxide dismutase, glutathione and glutathione peroxidase were determined in isolated kidney mitochondria. Our results show that guishe extracts have no antidiabetic properties at any dose. Nevertheless, it was able to diminish serum triglyceride levels and regulate the oxidative stress observed in isolated kidney mitochondria. These observations indicate that the aqueous extract from guishe can be used to treat abnormalities in serum lipids, as a hypolipidemic, and mitigate the oxidative stress, as an antioxidant, occurring during diabetes.
Keyphrases
- diabetic rats
- oxidative stress
- blood glucose
- body weight
- ischemia reperfusion injury
- dna damage
- induced apoptosis
- type diabetes
- cell death
- glycemic control
- hydrogen peroxide
- reactive oxygen species
- endoplasmic reticulum
- cardiovascular disease
- heat shock
- insulin resistance
- fatty acid
- metabolic syndrome
- risk assessment
- genetic diversity
- drug induced